Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J H Yuk

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Archives of Internal Medicine|December 11, 1991
Drug interaction with quinolone antibiotics in intensive care unit patientsT W Willams, J H Yuk
Archives of Internal Medicine|March 1, 1991
Drug interaction with quinolone antibiotics in intensive care unit patientsJ H Yuk, T W Williams
JAMA|August 18, 1989
Ciprofloxacin levels when receiving sucralfateJ H Yuk, C N Nightingale, R Quintiliani
Clinical Pharmacokinetics|October 1, 1989
Clinical pharmacokinetics of ceftriaxoneJ H Yuk, C H Nightingale, R Quintiliani
Clinical Pharmacokinetics|February 11, 1992
Considerations in dosage selection for third generation cephalosporinsJ H Yuk-Choi, C H Nightingale, T W Williams
Antimicrobial Agents and Chemotherapy|February 1, 1991
Bioavailability and pharmacokinetics of ofloxacin in healthy volunteersJ H Yuk, C H Nightingale, R Quintiliani, et al.
Reviews of Infectious Diseases|September 11, 1991
Minocycline as an alternative antistaphylococcal agentJ H Yuk, M C Dignani, R L Harris, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1989
Relative bioavailability in healthy volunteers of ciprofloxacin administered through a nasogastric tube with and without enteral feedingJ H Yuk, C H Nightingale, K R Sweeney, et al.
Journal of Vascular Surgery|November 1, 1991
Cefamandole levels during thoracoabdominal aortic aneurysm surgeryR L Harris, J H Yuk, C Cribari, et al.
Diagnostic Microbiology and Infectious Disease|March 1, 1990
Absorption of ciprofloxacin administered through a nasogastric or a nasoduodenal tube in volunteers and patients receiving enteral nutritionJ H Yuk, C H Nightingale, R Quintiliani, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Archives of Internal Medicine|December 11, 1991
Drug interaction with quinolone antibiotics in intensive care unit patientsT W Willams, J H Yuk
Archives of Internal Medicine|March 1, 1991
Drug interaction with quinolone antibiotics in intensive care unit patientsJ H Yuk, T W Williams
JAMA|August 18, 1989
Ciprofloxacin levels when receiving sucralfateJ H Yuk, C N Nightingale, R Quintiliani
Clinical Pharmacokinetics|October 1, 1989
Clinical pharmacokinetics of ceftriaxoneJ H Yuk, C H Nightingale, R Quintiliani
Clinical Pharmacokinetics|February 11, 1992
Considerations in dosage selection for third generation cephalosporinsJ H Yuk-Choi, C H Nightingale, T W Williams
Antimicrobial Agents and Chemotherapy|February 1, 1991
Bioavailability and pharmacokinetics of ofloxacin in healthy volunteersJ H Yuk, C H Nightingale, R Quintiliani, et al.
Reviews of Infectious Diseases|September 11, 1991
Minocycline as an alternative antistaphylococcal agentJ H Yuk, M C Dignani, R L Harris, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1989
Relative bioavailability in healthy volunteers of ciprofloxacin administered through a nasogastric tube with and without enteral feedingJ H Yuk, C H Nightingale, K R Sweeney, et al.
Journal of Vascular Surgery|November 1, 1991
Cefamandole levels during thoracoabdominal aortic aneurysm surgeryR L Harris, J H Yuk, C Cribari, et al.
Diagnostic Microbiology and Infectious Disease|March 1, 1990
Absorption of ciprofloxacin administered through a nasogastric or a nasoduodenal tube in volunteers and patients receiving enteral nutritionJ H Yuk, C H Nightingale, R Quintiliani, et al.
Pageof 1